Skip to main content
Gufic BioSciences Ltd. logo

Gufic BioSciences Ltd. — Investor Relations & Filings

Ticker · GUFICBIO ISIN · INE742B01025 LEI · 3358003C6YDH6EIDBP63 BSE.NS Manufacturing
Open in API
Filings indexed 1,192 across all filing types
Latest filing 2025-08-14 Regulatory Filings
Country IN India
Listing BSE.NS GUFICBIO

About Gufic BioSciences Ltd.

https://gufic.com/

Gufic BioSciences Ltd. focuses on the research, development, and large-scale manufacturing of pharmaceutical formulations and active pharmaceutical ingredients. The organization is distinguished by its specialized expertise in lyophilization technology, operating extensive facilities for the production of freeze-dried injectables. Its product portfolio encompasses a wide range of therapeutic areas, including critical care, infertility, oncology, and gastroenterology. In addition to conventional medicine, the company develops proprietary herbal and ayurvedic formulations through integrated scientific research. Gufic emphasizes advanced drug delivery systems and maintains a significant presence in the production of antibiotics, antifungal agents, and cardiac medications. The company serves a global clientele by providing high-quality generic and specialty healthcare solutions.

Recent filings

Filing Released Lang Actions
Audio Recording of Earnings Conference Call held on August 14, 2025 at 12:00 p.m. is attached herewith.
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges regarding the audio recording of an earnings conference call. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and states that the audio recording has been uploaded on the company's website. It also mentions that a written transcript will be submitted later. The document does not contain any financial data or detailed discussion of results, only an announcement about the availability of the audio recording and future transcript. Given the short length (1218 characters) and the nature of the content, this is an announcement related to a call transcript but not the transcript itself. According to the rules, announcements about reports or transcripts are classified as Regulatory Filings (RNS) unless the full transcript is included. Therefore, the correct classification is Regulatory Filings (RNS) with high confidence.
2025-08-14 English
Newspaper advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2025 is attached herewith.
Interim / Quarterly Report Classification · 95% confidence The document is a detailed communication addressed to stock exchanges regarding the publication of unaudited financial results for the quarter ended June 30, 2025. It includes extracts of financial data such as total income, net profit, earnings per share, and comprehensive income for the quarter and year-to-date periods. The document references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 33 and 47(1), which pertain to quarterly financial results disclosures. It also mentions that the full detailed financial results and limited review reports are available on stock exchange websites and the company's website. The document contains substantive financial data and analysis for a quarter, indicating it is a quarterly financial report rather than a mere announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2025-08-14 English
Investor Presentation on Unaudited Financial Results of the Company for the quarter ended June 30, 2025 is attached herewith
Investor Presentation Classification · 100% confidence The document is an investor presentation dated August 13, 2025, addressed to stock exchanges with a subject line explicitly stating 'Investor Presentation.' It discusses unaudited financial results for the quarter ended June 30, 2025, and includes detailed business highlights, strategic updates, product launches, and operational milestones. The content is typical of a presentation prepared for investors focusing on financials, strategy, and market position. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. The document is not a brief announcement or a regulatory filing but a detailed presentation. Therefore, the appropriate classification is Investor Presentation (IP).
2025-08-13 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is an extensive investor presentation dated August 13, 2025, addressed to stock exchanges with a subject line explicitly stating 'Investor Presentation'. It discusses unaudited financial results for the quarter ended June 30, 2025, and includes detailed business highlights, strategic updates, product launches, and operational milestones. The content is typical of an investor presentation focusing on financials, strategy, and market position rather than a formal financial report or regulatory filing. The length (15,000 characters) and detailed content confirm it is the presentation itself, not merely an announcement or certification. Therefore, the document fits the 'Investor Presentation' category (IP).
2025-08-13 English
Change in Auditors
Board/Management Information Classification · 95% confidence The document is a formal announcement addressed to stock exchanges regarding the re-appointment of the company's statutory auditors. It references compliance with SEBI Listing Regulations and provides details about the auditor firm and the term of appointment. The document does not contain financial statements or audit results but is an announcement of a board decision related to auditor appointment. This fits the category of Board/Management Information (MANG), as it concerns changes or appointments in key company roles (statutory auditors). The document length is 4083 characters, which is relatively short and consistent with an announcement rather than a full audit report or annual report.
2025-08-13 English
Intimation for Re-appointment of Statutory Auditors of the Company is attached herewith
Board/Management Information Classification · 95% confidence The document is a formal announcement addressed to stock exchanges regarding the re-appointment of the company's statutory auditors. It references compliance with SEBI Listing Regulations and provides details about the auditor firm and the term of appointment. The document does not contain financial statements or audit results but is an announcement of a board decision related to auditor appointment. This fits the category of Board/Management Information (MANG), as it concerns a change or confirmation in a key governance role (statutory auditor). The document length is 4083 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2025-08-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.